Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Share-based Compensation: 2021-2025

Historic Share-based Compensation for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $29.9 million.

  • Core Scientific's Share-based Compensation rose 45.91% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.3 million, marking a year-over-year increase of 107.48%. This contributed to the annual value of $51.9 million for FY2024, which is 11.83% down from last year.
  • As of Q3 2025, Core Scientific's Share-based Compensation stood at $29.9 million, which was up 23.90% from $24.2 million recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Share-based Compensation ranged from a high of $111.0 million in Q2 2022 and a low of -$1.1 million during Q1 2024.
  • For the 3-year period, Core Scientific's Share-based Compensation averaged around $16.5 million, with its median value being $16.2 million (2025).
  • As far as peak fluctuations go, Core Scientific's Share-based Compensation spiked by 5,096.54% in 2022, and later slumped by 108.64% in 2024.
  • Over the past 5 years, Core Scientific's Share-based Compensation (Quarterly) stood at $7.9 million in 2021, then skyrocketed by 106.26% to $16.3 million in 2022, then rose by 6.93% to $17.5 million in 2023, then skyrocketed by 37.13% to $24.0 million in 2024, then surged by 45.91% to $29.9 million in 2025.
  • Its Share-based Compensation stands at $29.9 million for Q3 2025, versus $24.2 million for Q2 2025 and $16.2 million for Q1 2025.